Photocure PHCUF Stock
Photocure Price Chart
Photocure PHCUF Financial and Trading Overview
| Photocure stock price | 5.65 USD |
| Previous Close | 5.65 USD |
| Open | 6.63 USD |
| Bid | 4.76 USD x 10000 |
| Ask | 5.76 USD x 10000 |
| Day's Range | 6.63 - 6.63 USD |
| 52 Week Range | 5.58 - 7.39 USD |
| Volume | 100 USD |
| Avg. Volume | 15 USD |
| Market Cap | 152.08M USD |
| Beta (5Y Monthly) | 0.319 |
| PE Ratio (TTM) | 18.833332 |
| EPS (TTM) | 0.3 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | May 23, 2013 |
| 1y Target Est | N/A |
PHCUF Valuation Measures
| Enterprise Value | -945153 USD |
| Trailing P/E | 18.833332 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.22406845 |
| Price/Book (mrq) | 2.3476603 |
| Enterprise Value/Revenue | -0.001 |
| Enterprise Value/EBITDA | -0.007 |
Trading Information
Photocure Stock Price History
| Beta (5Y Monthly) | 0.319 |
| 52-Week Change | 1.25% |
| S&P500 52-Week Change | 12.83% |
| 52 Week High | 7.39 USD |
| 52 Week Low | 5.58 USD |
| 50-Day Moving Average | 5.79 USD |
| 200-Day Moving Average | 6.52 USD |
PHCUF Share Statistics
| Avg. Volume (3 month) | 15 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 26.92M |
| Float | 20.03M |
| Short Ratio | N/A |
| % Held by Insiders | 2.39% |
| % Held by Institutions | 38.07% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 11.60% |
| Operating Margin (ttm) | -6.59% |
| Gross Margin | 93.58% |
| EBITDA Margin | 19.10% |
Management Effectiveness
| Return on Assets (ttm) | 8.55% |
| Return on Equity (ttm) | 14.49% |
Income Statement
| Revenue (ttm) | 678.72M USD |
| Revenue Per Share (ttm) | 25.36 USD |
| Quarterly Revenue Growth (yoy) | 5.09% |
| Gross Profit (ttm) | 635.2M USD |
| EBITDA | 129.7M USD |
| Net Income Avi to Common (ttm) | 78.74M USD |
| Diluted EPS (ttm) | 0.3 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 162.42M USD |
| Total Cash Per Share (mrq) | 6.03 USD |
| Total Debt (mrq) | 9.4M USD |
| Total Debt/Equity (mrq) | 1.55 USD |
| Current Ratio (mrq) | 3.647 |
| Book Value Per Share (mrq) | 2.4066515 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 98M USD |
| Levered Free Cash Flow (ttm) | 12.6M USD |
Profile of Photocure
| Country | United States |
| State | N/A |
| City | Oslo |
| Address | Hoffsveien 4 |
| ZIP | 0275 |
| Phone | 47 22 06 22 10 |
| Website | https://www.photocure.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 99 |
Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through two segments, Commercial Franchise and Development Portfolio. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It is also developing Cevira, a photodynamic drug-device combination product candidate for the non-surgical treatment of high-grade cervical dysplasia. The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira; and a strategic agreement with Richard Wolf GmbH to develop and commercialize a 4K LED high-definition reusable blue light cystoscope based on Richard Wolf's System blue technology. It sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. It has partnership with Artera for digital pathology AI test evaluation for bladder cancer. The company operates in the Nordic countries, Germany, France, Austria, the United Kingdom, the Benelux, Italy, other European countries, Canada, and the United States. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.
Q&A For Photocure Stock
What is a current PHCUF stock price?
Photocure PHCUF stock price today per share is 5.65 USD.
How to purchase Photocure stock?
You can buy PHCUF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Photocure?
The stock symbol or ticker of Photocure is PHCUF.
Which industry does the Photocure company belong to?
The Photocure industry is Drug Manufacturers - Specialty & Generic.
How many shares does Photocure have in circulation?
The max supply of Photocure shares is 26.92M.
What is Photocure Price to Earnings Ratio (PE Ratio)?
Photocure PE Ratio is 18.83333200 now.
What was Photocure earnings per share over the trailing 12 months (TTM)?
Photocure EPS is 0.3 USD over the trailing 12 months.
Which sector does the Photocure company belong to?
The Photocure sector is Healthcare.
